Diabetes Drugs Market
Diabetes Drugs Market
The global diabetes drugs market size is calculated at USD 75.16 billion in 2025 and is expected to be worth USD 134.73 billion by 2034, expanding at a CAGR of 6.7% from 2024 to 2034, as a result of the rising prevalence of diabetes, and rising patient support.
Report ID: 10044
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 70.44 Bn
Forecast Year,
USD USD 134.73 Bn
CAGR, 2025 -
6.7%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Diabetes Drugs Market Size Analysis
Diabetes Drugs Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulin | 28.18 | 29.99 | 32.24 | 33.97 | 36.89 | 38.48 | 42.20 | 43.59 | 48.28 | 49.37 | 55.24 |
| DPP- 4 Inhibitors | 14.09 | 15.11 | 15.88 | 17.37 | 17.90 | 19.97 | 20.17 | 22.96 | 22.72 | 26.39 | 25.60 |
| GLP-1 Receptor Agonists | 17.61 | 18.71 | 20.21 | 21.14 | 23.19 | 23.87 | 26.61 | 26.95 | 30.53 | 30.43 | 35.03 |
| SGLT2 Inhibitors | 10.57 | 11.35 | 11.87 | 13.09 | 13.33 | 15.10 | 14.97 | 17.41 | 16.80 | 20.08 | 18.86 |
Diabetes Drugs Market Size By Diabetes Type 2024 to 2034 (USD )
| Diabetes Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Type 1 | 17.61 | 18.71 | 20.21 | 21.14 | 23.19 | 23.87 | 26.61 | 26.95 | 30.53 | 30.43 | 35.03 |
| Type 2 | 52.83 | 56.44 | 59.99 | 64.43 | 68.11 | 73.55 | 77.34 | 83.96 | 87.81 | 95.84 | 99.70 |
Diabetes Drugs Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 35.22 | 37.54 | 40.18 | 42.66 | 45.83 | 48.46 | 52.28 | 55.06 | 59.64 | 62.56 | 68.03 |
| Subcutaneous | 31.70 | 33.93 | 35.86 | 38.88 | 40.56 | 44.55 | 45.88 | 51.04 | 51.89 | 58.48 | 58.69 |
| Intravenous | 3.52 | 3.69 | 4.16 | 4.03 | 4.91 | 4.41 | 5.79 | 4.80 | 6.81 | 5.22 | 8.00 |
Diabetes Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Online pharmacies | 10.57 | 11.21 | 12.17 | 12.62 | 14.00 | 14.20 | 16.12 | 15.97 | 18.55 | 17.97 | 21.34 |
| Hospital Pharmacies | 24.65 | 26.41 | 27.85 | 30.30 | 31.46 | 34.76 | 35.54 | 39.87 | 40.15 | 45.74 | 45.35 |
| Retail pharmacies | 35.22 | 37.54 | 40.18 | 42.66 | 45.83 | 48.46 | 52.28 | 55.06 | 59.64 | 62.56 | 68.03 |
Diabetes Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 28.18 | 30.04 | 32.14 | 34.13 | 36.65 | 38.79 | 41.80 | 44.08 | 47.68 | 50.10 | 54.37 |
| Europe | 19.72 | 21.10 | 22.33 | 24.16 | 25.28 | 27.65 | 28.63 | 31.65 | 32.41 | 36.23 | 36.70 |
| Asia-Pacific | 15.50 | 16.50 | 17.72 | 18.70 | 20.26 | 21.20 | 23.16 | 24.04 | 26.48 | 27.24 | 30.27 |
| Latin America | 3.52 | 3.81 | 3.91 | 4.44 | 4.34 | 5.18 | 4.81 | 6.04 | 5.32 | 7.03 | 5.89 |
| Middle East & Africa | 3.52 | 3.72 | 4.10 | 4.13 | 4.77 | 4.59 | 5.55 | 5.10 | 6.45 | 5.66 | 7.50 |
Diabetes Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
